Tag: Shore Capital Partners
Why is Walgreens shopping its home infusion biz?
September 26, 2014Theresa Flaherty, Managing Editor
DEERFIELD, Ill. - News that Walgreens is mulling the sale of a controlling stake in its home infusion business came as no surprise to analysts.“I think Walgreens recognizes that this is a core asset and would probably be valued quite substantially by a third party,” said Justin Ishbia, founder and managing partner of Shore Capital Partners. “There will be a lot of interest from a lot of people.”The news of the potential sale follows CVS Caremark's acquisition of Coram from...
Home Infusion, Shore Capital Partners, The Braff Group, Walgreens Infusion Services
Sponsored Stories
How Advanced Diabetes Supply is Driving Value-Based Health Outcomes
By Advanced Diabetes SupplySOS Achieves Remarkable 400% Growth in 2023, Bolsters Team with Director Appointment
By Strategic Office SupportCyber Siege: The Financial Vulnerability Healthcare Didn't See Coming
By Strategic Office SupportA new staffing model that delivers ready-to-work pros, boosting efficiency and lowering costs.
By Tactical Back Office